Literature DB >> 9371911

Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation.

U Ziemann1, M Winter, C D Reimers, K Reimers, F Tergau, W Paulus.   

Abstract

We investigated 14 patients with amyotrophic lateral sclerosis (ALS) by paired conditioning-test transcranial magnetic stimulation to test the hypothesis that the motor cortex is hyperexcitable in ALS. Intracortical (corticocortical) inhibition was significantly less in the ALS group than in an age-matched healthy control group (85.3 +/- 27.0% versus 45.2 +/- 15.5%, respectively; p < 0.0001). In contrast, intracortical facilitation, motor threshold, and cortical silent period duration in the ALS patients were not different from the control group. We suggest that the selective abnormality of intracortical inhibition is best compatible with an impaired function of inhibitory interneuronal circuits in the motor cortex that in turn renders the corticomotoneuron hyperexcitable.

Entities:  

Mesh:

Year:  1997        PMID: 9371911     DOI: 10.1212/wnl.49.5.1292

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

Review 1.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

2.  Further evidence to support different mechanisms underlying intracortical inhibition of the motor cortex.

Authors:  Ritsuko Hanajima; Toshiaki Furubayashi; Nobue Kobayashi Iwata; Yasushi Shiio; Shingo Okabe; Ichiro Kanazawa; Yoshikazu Ugawa
Journal:  Exp Brain Res       Date:  2003-06-27       Impact factor: 1.972

3.  Excitability changes in human peripheral nerve axons in a paradigm mimicking paired-pulse transcranial magnetic stimulation.

Authors:  Jane H L Chan; Cindy S-Y Lin; Emmanuel Pierrot-Deseilligny; David Burke
Journal:  J Physiol       Date:  2002-08-01       Impact factor: 5.182

4.  Patterns of cortical activity differ in ALS patients with limb and/or bulbar involvement depending on motor tasks.

Authors:  Katja Kollewe; Thomas F Münte; Amir Samii; Reinhard Dengler; Susanne Petri; Bahram Mohammadi
Journal:  J Neurol       Date:  2010-12-03       Impact factor: 4.849

5.  Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis.

Authors:  M Sommer; F Tergau; S Wischer; C D Reimers; W Beuche; W Paulus
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

Review 6.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

7.  A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.

Authors:  Michael D Weiss; Eric A Macklin; Zachary Simmons; Angela S Knox; David J Greenblatt; Nazem Atassi; Michael Graves; Nicholas Parziale; Johnny S Salameh; Colin Quinn; Robert H Brown; Jane B Distad; Jaya Trivedi; Jeremy M Shefner; Richard J Barohn; Alan Pestronk; Andrea Swenson; Merit E Cudkowicz
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

8.  Amyotrophic lateral sclerosis affects cortical and subcortical activity underlying motor inhibition and action monitoring.

Authors:  Bahram Mohammadi; Katja Kollewe; David M Cole; Anja Fellbrich; Marcus Heldmann; Amir Samii; Reinhard Dengler; Susanne Petri; Thomas F Münte; Ulrike M Krämer
Journal:  Hum Brain Mapp       Date:  2015-04-24       Impact factor: 5.038

9.  Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.

Authors:  M R Turner; A D Osei-Lah; A Hammers; A Al-Chalabi; C E Shaw; P M Andersen; D J Brooks; P N Leigh; K R Mills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

10.  Relationship between transcranial magnetic stimulation measures of intracortical inhibition and spectroscopy measures of GABA and glutamate+glutamine.

Authors:  Sara Tremblay; Vincent Beaulé; Sébastien Proulx; Louis de Beaumont; Malgorzata Marjanska; Julien Doyon; Alvaro Pascual-Leone; Maryse Lassonde; Hugo Théoret
Journal:  J Neurophysiol       Date:  2012-12-05       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.